Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Bifidobacterium Lactis,Lactobacillus Gasseri,Lactobacillus Rhamnosus
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioma Probiotics Launches Women’s Gut Health Formula for Natural Weight Loss
Details : Bioma Probiotics supports weight loss, balances gut health, and helps women reduce bloating, boost energy, and improve digestion naturally.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
August 05, 2025
Lead Product(s) : Bifidobacterium Lactis,Lactobacillus Gasseri,Lactobacillus Rhamnosus
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Acidophilus,Bifidobacterium Lactis,Saccharomyces Boulardii
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioma Probiotics Officially Launches: A Revolutionary Step Toward Total Gut Health
Details : Bioma Probiotics is a potent blend of prebiotics, probiotics, and postbiotics to help nourish the gut, reduce bloating, enhance energy, and support weight management.
Product Name : Bioma Probiotics
Product Type : Probiotic
Upfront Cash : Inapplicable
June 23, 2025
Lead Product(s) : Lactobacillus Acidophilus,Bifidobacterium Lactis,Saccharomyces Boulardii
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bifidobacterium Lactis
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Medical University of Lublin
Deal Size : Inapplicable
Deal Type : Inapplicable
The Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 01, 2021
Lead Product(s) : Bifidobacterium Lactis
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Medical University of Lublin
Deal Size : Inapplicable
Deal Type : Inapplicable